Concepedia

Author

K. Koch

Roche (United States)

Also Known As

K Koch, K. -M. Koch, K. Koch, K. M. Koch, K.M. Koch, Kai Koch, Khristina Koch, Klaus Koch, Susie Q. Lew

46

Publications

774

Citations

12

H-Index

37

Concepts

All Affiliations

Roche (United States)Medizinische Hochschule Hannover
KK

About

K. Koch is an author at Roche (United States) specializing in medicine, pharmacology, and nephrology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

248

2

Biochemistry

2

2

30

3

Health Sciences

1

1

101

4

Natural Sciences

1

1

17

5

Chemical Biology

1

1

17

K. Koch

×

10

Publications

304

Citations

10

H-Index

YearCitations

Rifampin Reduces Early Mortality in Experimental<i>Streptococcus pneumoniae</i>Meningitis

Roland Nau, Andreas Wellmer, Adriana Soto,

The Journal of Infectious Diseases

1999

101

Disposition pharmacokinetics of bezafibrate in man

U. Abshagen, W. Bablok, K. Koch,

European Journal of Clinical Pharmacology

1979

61

Kinetics of canrenone after single and multiple doses of spironolactone

U. Abshagen, E Besenfelder, R. Endele,

European Journal of Clinical Pharmacology

1979

42

?-Methyl-digoxin

W. Schaumann, K. Koch

Naunyn-Schmiedeberg s Archives of Pharmacology

1974

21

Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.

C. Schümichen, K. Koch, Albert L. Kraus,

PubMed

1980

17

Eosinophilia in Hemodialysis

E. Scheuermann, W Fassbinder, U Frei,

Contributions to nephrology

2015

14

ISolation and identification of a sulfur-containing metabolite of spironolactone from human urine

U. Abshagen, H. Rennekamp, K. Koch,

Steroids

1976

13

?-Methyl-digoxin

W. Schaumann, K. Koch

Naunyn-Schmiedeberg s Archives of Pharmacology

1974

13

?-Methyl-digoxin

W. Voigtl�nder, W. Schaumann, K. Koch,

Naunyn-Schmiedeberg s Archives of Pharmacology

1972

12

?-Methyl-digoxin

W. Schaumann, F. Zielske, Karola Köhler,

Naunyn-Schmiedeberg s Archives of Pharmacology

1972

10

Page 1